Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Liposomal Doxorubicin and Estramustine Phosphate: A Phase II Study in Taxane Resistant, Hormone Refractory Advanced Prostate Cancer

NCT00132756 is registered in ClinicalTrials.gov with Morton Plant Mease Health Care as lead sponsor.

NCT NCT00132756
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00132756 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Liposomal Doxorubicin and Estramustine Phosphate: A Phase II Study in Taxane Resistant, Hormone Refractory Advanced Prostate Cancer
Lead sponsor
Morton Plant Mease Health Care
Phase
Phase 1/2
Overall status
Terminated
Start date
December 31, 2003
Completion date
Not reported
Enrollment
30
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

prostate cancer